EverPoint Asset Management’s Haemonetics HAE Stock Holding History

EverPoint Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$9.73M	Buy	+241,955	New	+$9.12M	0.18%	145

Other funds holding HAE

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EverPoint Asset Management's HAE Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Haemonetics (HAE) in Q4 2016: 241,955 shares worth $9.73M. The stake represents 0.18% of the portfolio and ranks #145 among its holdings.

197 funds tracked by Wall St. Rank hold HAE as of Q4 2016.

EverPoint Asset Management held 241,955 shares of Haemonetics worth $9.73M as of Q4 2016.
Haemonetics was a new EverPoint Asset Management position in Q4 2016.
Haemonetics made up 0.18% of EverPoint Asset Management's portfolio in Q4 2016, its #145 holding.
197 funds tracked by Wall St. Rank held Haemonetics as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.